AstraZeneca Readies New Portfolio of Targeted Cancer Therapies
来源：WSJ发布于 2026-10-26
AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to cement its position in one of the fastest-growing corners of the oncology marke...
相关标的：AZN
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。